Have you had a Kidney Stone ?

Kidney stones can be incredibly painful and disruptive, but they also inspire us to find better treatments, support, and solutions for those affected. At the Kidney Stone Engagement Core (KSEC), we are a team dedicated to transforming kidney stone disease research. Our mission is to improve the lives of patients, caregivers, and clinicians by fostering collaboration and making sure our research directly reflects the needs of those who are most impacted.

 

Find A Study

To help us match you to clinical trials. Enter your zip/postal code to see trial sites in your area.

Who We Are

KSEC brings together a unique group of 16 individuals, including clinicians, researchers, patients who have experienced kidney stones, a caregiver, and a patient advocate. By uniting medical expertise with firsthand patient experience, we aim to close the gap between research and real-world challenges. Together, we are committed to driving meaningful change in kidney stone treatment and care.

 

If you’ve had a kidney stone or are interested in contributing to research that truly makes a difference, join us in our mission. Your voice can help shape the future of kidney stone research and ensure that the needs and priorities of patients are always at the forefront.

Joining KSEC at the beginning of 2024 deepened my commitment to empowering others through effective communication and advocacy.

Get Involved

Are you interested in learning more about how to join the Kidney Stone Engagement Core?

What We Do

Our mission is to revolutionize kidney stone research by actively engaging patients, caregivers, clinicians, and researchers. Through the Kidney Stone Engagement Core (KSEC), we are pioneering a patient-centered approach to comparative effectiveness research. We collaborate at every stage of clinical trial design, from identifying research questions to selecting meaningful outcomes, and from designing patient-centered trials to contextualizing results. 

Prioritized Research Agenda

The incidence of kidney stone disease in the United States has doubled over 15 years with a prevalence now equivalent to that of diabetes. Despite the high morbidity of kidney stones, most existing medical and surgical treatments for children and adults with kidney stones are not supported by high-quality evidence. In addition, use of patient-reported outcomes in existing trials is lacking. We thus propose a multi-staged approach to strengthen the existing infrastructure of stakeholder engagement in PKIDS, expanding inclusion to adult patients and other key stakeholder groups, in order to define a research agenda for comparative-effectiveness trials in kidney stone disease that reflects the priorities of all stakeholders. The patient-prioritized research agenda will include actionable patient-centered recommendations for surgical and medical trials for adults and children with kidney stones and will create an integrated group of stakeholders for partnership in these trials.

Sign Up for Our Newsletter

Meet Our Team

KSEC is currently composed of individuals, including clinicians and researchers, patients with kidney stones, a caregiver of a patient with kidney stones, and a patient advocate. Specific to clinical trial design, patient and stakeholder engagement can be applied at multiple steps in the process, including identification of research questions, selection of key trial outcomes including relevance to patients and stakeholders, input on pragmatic and patient-centered trial design, and contextualization of results.

Dirk
Katherine
Annabelle
Greg

KSEC Partners

Our Work

KSEC members are involved in several efforts to amplify the voice of patients and caregivers for kidney stone disease. Click below to learn more.

PKIDS

PKIDS stands for the Pediatric KIDney Stone Care Improvement Network. We are a community of patients, caregivers, clinicians, and researchers who perform collaborative studies of

Read More »

Practical Work

Methods:
Our protocol includes 3 phases: elicitation of key research themes, refinement of research themes into research questions, and prioritization of research questions into

Read More »

Find A Study

To help us match you to clinical trials. Enter your zip/postal code to see trial sites in your area.

Get Involved

Email us your interest in becoming more involved with KSEC

Dr. Dirk Lange is an Associate Professor in the Department of Urologic Sciences at the University of British Columbia and the Director of Basic Science Research at The Stone Centre at Vancouver General Hospital (VGH). After completing his PhD in Microbiology & Immunology at the University of Western Ontario (London, Ontario, Canada), Dr. Lange joined The Stone Centre at VGH Hospital in 2008 as a post-doctoral fellow and transitioned into a full faculty position in the Department of Urologic Sciences in 2011.  

Dr. Lange has been instrumental in building an internationally renowned translational research and training program at The Stone Centre at VGH, dedicated to the development of novel treatment options for recurrent kidney stone disease. He is viewed as one of the leading experts in understanding mechanisms behind indwelling ureteral stent-associated complications including infections and the ureteral response to indwelling stents and how this translates to patient discomfort. Given Dr. Lange’s expertise in Microbiology, his research program is also expanding our understanding of the roles of the intestinal and urinary microbiota in the development and treatment of urologic disease including recurrent kidney stone disease, kidney transplant rejection and bladder cancer.  

Overall, Dr. Lange brings a new perspective on various aspects of urological research, resulting in the development of new and innovative research leading to novel treatment and preventative options. 

Katherine Parker (KSEC Manager)

 I am the research coordinator, project and engagement manager for the Kidney Stone Engagement Core at the Medical College of Wisconsin and Children’s Wisconsin.  I have a degree in Neuroscience/ Psychology and have worked in research for 8 years with 4 years of clinical research in pediatric urology. Our team is dedicated to lessening the burden of kidney stones for patients and families by building partnerships with patients, caregivers, researchers and clinicians by developing research and clinical tools to improve their experience. Outside of my work, I am a martial artist, taekwondo instructor, amateur photographer, and mother.

 

As a kidney stone patient since age 15, I have self-advocated through various challenges, which motivated my educational endeavors in the study of health literacy. Joining KSEC at the beginning of 2024 deepened my commitment to empowering others through effective communication and advocacy. 

Gregory Tasian MD, MSc, MSCE 

Dr. Tasian a tenured Associate Professor of Surgery and Epidemiology at the University of Pennsylvania Perelman School of Medicine. His research program is based at the Children’s Hospital of Philadelphia (CHOP), where he is a practicing pediatric urologist specializing in the surgical and medical management of children with kidney stone disease. He completed his Urology residency at UCSF and pediatric urology fellowship at CHOP. Dr. Tasian earned Masters of Science degrees in neuroscience (Oxford) and clinical epidemiology (Penn). He is the Director of the 30-site PCORI- and NIH-funded Pediatric KIDney Stone (PKIDS) Care Improvement Network and leads CHOP’s Center for Outcomes REsearch in Surgery (CORES). His research group uses a combination of randomized trials, prospective observational studies, and large data analytics to generate knowledge that improves outcomes for individuals with kidney stone disease across the lifespan. His research program has been continuously supported by the NIH and PCORI since he finished fellowship and he has published over 150 research articles in leading peer-reviewed journals. His research has been covered extensively in the press, including The New York Times, ABC News, The Guardian, and CNN. 

He is most passionate about applying research to improve the health of children.